ClinicalTrials.gg
Not yet recruitingNCT07657637Updated Jun 18, 2026

Efficacy of Diclofenac Sodium Shock Wave Phonophoresis on Patients With Subacromial Impingement Syndrome

An interventional study of sodium diclofenac radial shock wave phonophoresis plus conventional physical therapy and radial shock wave therapy plus conventional physical therapy in Shock Wave and Subacromial Impingement Syndrome, sponsored by MTI University. Not yet recruiting at 1 site in Egypt. Open to participants aged 25 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-06-18.

Sponsored by MTI University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
25 Years to 40 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 34 studies in Shoulder Impingement Syndrome with a site in Egypt — 15 open to participants now, 17 under way, none of them phase 3. Shoulder Impingement Syndrome · Egypt.

Planned enrollment
3rd of 30
70 · median 50
Started
2026
with 5 others
No phase
30 of 34
12 open now
Primary completion
2026-10
later than 12 of 16 live
Registered
33rd of 34
by date
Lead sponsor
2 of 34
MTI University

Among the 34 studies in Shoulder Impingement Syndrome with a site in Egypt, this one is the 3rd largest by planned enrollment of the 30 interventional ones that give a count, is one of 6 that started in 2026, is one of 30 with no phase, reaches primary completion later than 12 of the 16 other live ones, and was the 33rd registered.

Shoulder Impingement Syndrome

320 studies on the registry are indexed under Shoulder Impingement Syndrome; 62 are open to participants now.

Browse Shoulder Impingement Syndrome studies →

Open to participants now

15 of the 34 studies in Shoulder Impingement Syndrome with a site in Egypt are open now. Recruiting first, the newest first:

9 more — sign in →

All 15 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 32 Shoulder Impingement Syndrome studies recruiting now, 3 (9%) set no upper age limit and 25 (78%) stop at 75 or younger; 1 take children under 18; 6 take healthy volunteers.

This study: 25 Years to 40 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 34 studies in Shoulder Impingement Syndrome with a site in Egypt, or all of them as a file.
02

Study summary

The goal of the study is to determine the effect of radial shock wave Phonophoresis on patients with impingement syndromes. to answer the following questions:

does shock wave Phonophoresis have and effect on pain? does shock wave Phonophoresis have and effect on shoulder function? does shock wave Phonophoresis have and effect on subacromial space? patients will be randomized to two groups: Group (A): patients will receive shock wave Phonophoresis plus conventional physical therapy.

Group (B): Patients will receive shock wave plus conventional Physical therapy.

03

Conditions studied

  • Shock Wave
  • Subacromial Impingement Syndrome
04

Who can participate

Ages eligible
25 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients age range between 25-40 years ago.
  • Shoulder pain between 60- 120° with shoulder elevation (positive painful arch test).
  • Grade 2 impingement syndrome according to neer classification.

Exclusion criteria

Exclusion Criteria:

  • Shoulder affected bilaterally
  • Receiving anesthetic or injections within 4 weeks of study enrollment
  • Surgery or previous fractures of the ipsilateral humeral head of the affected shoulder
  • Osteoarthritis in the acromioclavicular or glenohumeral joints
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    sodium diclofenac radial shock wave Phonophoresis plus conventional physical therapy

    sodium diclofenac radial shock wave Phonophoresis plus conventional physical therapyc

    Device: sodium diclofenac radial shock wave phonophoresis plus conventional physical therapy

  • Active comparator
    radial shock wave plus conventional physical therapy

    radial shock wave plus conventional physical therapy

    Device: radial shock wave therapy plus conventional physical therapy

Interventions

  • Devicesodium diclofenac radial shock wave phonophoresis plus conventional physical therapy

    patients will receive radial shock wave Phonophoresis by ibuprofen in the form of 2000 shocks, 2.4 bars, 10 MHz frequency plus (strengthening and stretching exercises for subraspinatus muscle).

  • Deviceradial shock wave therapy plus conventional physical therapy

    patients will receive radial shock wave therapy ( 2000 shocks, 2.4 bars, 10 MHz), plus conventional physical therapy (strengthening and stretching exercises for subraspinatus muscle).

06

What researchers measure

Primary outcomes

  1. subacromial space

    Time frame: before the first session and after the last session ( four weeks)

  2. shoulder pain

    shoulder pain will be measured by numerical pain scale

    Time frame: before the first session and after the last session ( four weeks)

Secondary outcomes

  1. shoulder function

    function will be measured by shoulder pain and disability index

    Time frame: Time Frame: before the first session and after the last session ( four weeks)

07

Study locations

1 site
  • Modern University for Technology and Information, Cairo, , Egypt
    Cairo, Egypt
    • Modern University for Technology and Information · Contactinfo@mti.edu.eg · 19041
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2026; primary completion for Oct 2026, 3 months later.

Of 170 non-industry interventional studies with no phase under Shoulder Impingement Syndrome, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 24. This study's planned 3 months is below that.

Counting every sponsor, half of 172 studies reached it within 12 months; a quarter within 5 and three quarters within 24.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 14, 2026
First posted
Jun 18, 2026
StartEst.
Jun 30, 2026
Primary completionEst.
Oct 1, 2026
CompletionEst.
Oct 30, 2026
Last update
Jun 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07657637
Lead sponsor
MTI University
Responsible party
Radwa Fayek Hammam (Lecturer of basic science department faculty of physical therapy, MTI University) — Principal investigator
First posted
Jun 18, 2026
Start date
Jun 30, 2026 (estimated)
Primary completion
Oct 1, 2026 (estimated)
Completion
Oct 30, 2026 (estimated)
Last update
Jun 18, 2026

Study contacts

radwa fayek lecturer, Phd
Contact
radwa26fayek@yahoo.com
02-01004466229

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion